The “old” criteria I2010 and III2010 have been slightly altered, and are now listed as criteria
I2019 and II2019 in the updated guideline of 2019 (Figure 1). For criterion I2010, 2 …

Serrated polyposis syndrome (SPS; formerly 'hyperplastic polyposis syndrome') has
emerged as by far the most common colorectal polyp syndrome. 1 2 SPS is characterised by …

Objective Serrated polyposis syndrome (SPS) is associated with an increased colorectal
cancer (CRC) risk, although the magnitude of the risk remains uncertain. Whereas intensive …

Objective Serrated polyposis syndrome (SPS) is accompanied by an increased risk of
colorectal cancer (CRC). Patients fulfilling the clinical criteria, as defined by the WHO, have …

Background and study aims: The most frequently cited prevalence for serrated polyposis
syndrome (SPS) is 1 in every 3000 people screened, but this value is debated. Additionally …

Background & aims Serrated polyposis syndrome (SPS) is characterized by development of
numerous serrated lesions throughout the colorectum and increased risk of colorectal …

Serrated polyposis syndrome (SPS) is poorly defined and patients have an increased but
unspecified risk for colorectal carcinoma through the serrated pathway. Despite this …

Objective The role of serrated polyps (SPs) as colorectal cancer precursor is increasingly
recognised. However, the true prevalence SPs is largely unknown. We aimed to evaluate …

Serrated polyposis syndrome (SPS) is a recently recognised high risk condition for
colorectal cancer (CRC) characterised by the presence of large and/or multiple serrated …

Background and study aims Serrated polyposis syndrome (SPS) is a high risk condition for
colorectal cancer (CRC). Surveillance strategies for patients with serrated lesions remain …